Successful long-term treatment of hepatic carnitine palmitoyltransferase I deficiency and a novel mutation

被引:13
|
作者
Stoler, JM
Sabry, MA
Hanley, C
Hoppel, CL
Shih, VE
机构
[1] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Pediat Serv,Genet & Teratol Unit, Boston, MA 02114 USA
[2] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Amino Acid Disorders Lab, Boston, MA 02114 USA
[3] Massachusetts Gen Hosp, Nutr & Food Serv, Boston, MA 02114 USA
[4] Rainbow Babies & Childrens Hosp, Dept Pediat, Ctr Inherited Disorders Energy Metab, Cleveland, OH 44106 USA
关键词
D O I
10.1023/B:BOLI.0000042979.42120.55
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Individuals with carnitine palmitoyltransferase I (CPT-I) deficiency cannot metabolize long-chain fatty acids and can develop life-threatening hypoglycaemia. We present a boy with CPT-I deficiency maintained on a very low-fat diet with nighttime uncooked cornstarch feedings for 51/2 years with good success. He has had normal growth and no episodes of hypoglycaemia or adverse side-effects. We found that he was homozygous for a previously undescribed mutation, T314I, in the CPT1A protein.
引用
收藏
页码:679 / 684
页数:6
相关论文
共 50 条
  • [21] Postoperative coma in a child with carnitine palmitoyltransferase I deficiency
    Neuvonen, PT
    van den Berg, AA
    ANESTHESIA AND ANALGESIA, 2001, 92 (03): : 646 - 647
  • [22] Effects of carnitine palmitoyltransferase I inhibitors on hepatic hypertrophy
    Yotsumoto, T
    Naitoh, T
    Kitahara, M
    Tsuruzoe, N
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2000, 398 (02) : 297 - 302
  • [23] Lethal neonatal presentation of carnitine palmitoyltransferase I deficiency
    Invernizzi, F
    Burlina, AB
    Donadio, A
    Giordano, G
    Taroni, F
    Garavaglia, B
    JOURNAL OF INHERITED METABOLIC DISEASE, 2001, 24 (05) : 601 - 602
  • [24] Novel mutations associated with carnitine palmitoyltransferase II deficiency
    Taggart, RT
    Smail, D
    Apolito, C
    Vladutiu, GD
    HUMAN MUTATION, 1999, 13 (03) : 210 - 220
  • [25] A novel nonsense mutation (515del4) in muscle carnitine palmitoyltransferase II deficiency
    Deschauer, M
    Wieser, T
    Schröder, R
    Zierz, S
    MOLECULAR GENETICS AND METABOLISM, 2002, 75 (02) : 181 - 185
  • [26] CARNITINE PALMITOYLTRANSFERASE-II DEFICIENCY WITH NORMAL CARNITINE PALMITOYLTRANSFERASE-I IN SKELETAL-MUSCLE AND LEUKOCYTES
    SCHOLTE, HR
    JENNEKENS, FGI
    BOUVY, JJBJ
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 1979, 40 (01) : 39 - 51
  • [27] Molecular assay for the characterization of hepatic carnitine palmitoyltransferase 1 deficiency.
    Park, JY
    Narayan, S
    Bennett, MJ
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2005, 124 (03) : 455 - 455
  • [28] ATYPICAL FEATURES OF THE HEPATIC FORM OF CARNITINE PALMITOYLTRANSFERASE DEFICIENCY IN A HUTTERITE FAMILY
    HAWORTH, JC
    DEMAUGRE, F
    BOOTH, FA
    DILLING, LA
    MOROZ, SP
    SESHIA, SS
    SEARGEANT, LE
    COATES, PM
    JOURNAL OF PEDIATRICS, 1992, 121 (04): : 553 - 557
  • [29] LONG-TERM TREATMENT WITH L-CARNITINE IN THE SECONDARY SYSTEMIC CARNITINE DEFICIENCY OF RENAL FANCONI SYNDROME
    NETZLOFF, ML
    KOHRMAN, AF
    JONES, MZ
    DIMAURO, S
    BIEBER, LL
    PEDIATRIC RESEARCH, 1986, 20 (04) : A333 - A333
  • [30] Pancreatitis and rhabdomyolysis in a patient with carnitine palmitoyltransferase I deficiency.
    Laman, D
    Steffen, R
    Wyllie, R
    Kay, M
    Kaplan, B
    GASTROENTEROLOGY, 2000, 118 (04) : A1148 - A1149